Skip to main content
SpringerLink
Log in

The Antibiotic Resistance in Acne

  • Chapter
Pathogenesis and Treatment of Acne and Rosacea

  • 3101 Accesses

Abstract

P. acnes, as well as the other Propionibacterium species, are generally but not universally susceptible to a large variety of antimicrobials [1–3]. Propionibacterium species are generally resistant to 5-nitroimidazole agents (metronidazole, tinidazole, and ornidazole), aminoglycosides, and mupirocin [4, 5].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 239.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bansal MB, Chuah SK, Thadepalli H. Susceptibility of intestinal anaerobes to new beta-lactam antibiotics. Chemotherapy. 1984;30:237–43.

    Article  CAS  PubMed  Google Scholar 

  2. Chow AW, Bednorz D. Comparative in vitro activity of newer cephalosporins against anaerobic bacteria. Antimicrob Agents Chemother. 1978;14:668–71.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Denys GA, Jerris RC, Swenson JM, et al. Susceptibility of Propionibacterium acnes clinical isolates to 22 antimicrobial agents. Antimicrob Agents Chemother. 1983;23:335–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Brook I. Propionibacterium acnes. In: Yu VL, Weber R, Raoult D, editors. Antimicrobial therapy and vaccines; 2002. New York, NY: Apple Tree Productions

    Google Scholar 

  5. Eady EA, Gloor M, Leyden JJ. Propionibacterium acnes resistance: a worldwide problem. Dermatology. 2003;206:54–6.

    Article  CAS  PubMed  Google Scholar 

  6. Leyden JJ, McGinley KJ, Mills OH, et al. Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol. 1975;65:382–4.

    Article  CAS  PubMed  Google Scholar 

  7. Crawford WW, Crawford IP, Stoughton RB, et al. Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes. J Invest Dermatol. 1979;72:187–90.

    Article  CAS  PubMed  Google Scholar 

  8. Oprica C, Emtestam L, Lapins J, et al. Antibiotic resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm. Anaerobe. 2004;10:155–64.

    Article  PubMed  Google Scholar 

  9. Ross JI, Snelling AM, Carnegie E, et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol. 2003;148:467–78.

    Article  CAS  PubMed  Google Scholar 

  10. Eady EA. Bacterial resistance in acne. Dermatology. 1998;196:59–66.

    Article  CAS  PubMed  Google Scholar 

  11. Coates P, Vyakrnam S, Eady EA, et al. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol. 2002;146:840–8.

    Article  CAS  PubMed  Google Scholar 

  12. Ross JI, Eady EA, Cove JH, et al. Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob Agents Chemother. 1997;41:1162–5.

    PubMed Central  CAS  PubMed  Google Scholar 

  13. Ross JI, Eady EA, Carnegie E, et al. Detection of transposon Tn5432-mediated macrolide-lincosamide-streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities. J Antimicrob Chemother. 2002;49:165–8.

    Article  CAS  PubMed  Google Scholar 

  14. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis. 2002;34:482–92.

    Article  CAS  PubMed  Google Scholar 

  15. Ross JI, Eady EA, Cove JH, et al. 16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrob Agents Chemother. 1998;42:1702–5.

    PubMed Central  CAS  PubMed  Google Scholar 

  16. Ross JI, Snelling AM, Eady EA, et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br J Dermatol. 2001;144:339–46.

    Article  CAS  PubMed  Google Scholar 

  17. Eady EA, Cove JH, Layton AM. Is antibiotic resistance in cutaneous propionibacteria clinically relevant? implications of resistance for acne patients and prescribers. Am J Clin Dermatol. 2003;4:813–31.

    Article  PubMed  Google Scholar 

  18. Dreno B, Bettoli V, Ochsendorf F, et al. European recommendations on the use of oral antibiotics for acne. Eur J Dermatol. 2004;14:391–9.

    PubMed  Google Scholar 

  19. Burkhart CN, Burkhart CG. Microbiology’s principle of biofilms as a major factor in the pathogenesis of acne vulgaris. Int J Dermatol. 2003;42:925–7.

    Article  CAS  PubMed  Google Scholar 

  20. Burkhart CG, Burkhart CN. Expanding the microcomedone theory and acne therapeutics: Propionibacterium acnes biofilm produces biological glue that holds corneocytes together to form plug. J Am Acad Dermatol. 2007;57:722–4.

    Article  PubMed  Google Scholar 

  21. Oprica C. Characterization of antibiotic-resistant Propionibacterium acnes from acne vulgaris and other diseases. Dermatology and Clinical Bacteriology. Thesis; 2006. Karolinska Institutet Publisher Stockholm

    Google Scholar 

  22. Sapadin AN, Fleischmajer R. Tetracyclines: Nonantibiotic properties and their clinical implications. J Am Acad Dermatol. 2006;54:258–65.

    Article  PubMed  Google Scholar 

  23. Eady EA, Cove JH, Holland KT, et al. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol. 1989;121:51–7.

    Article  CAS  PubMed  Google Scholar 

  24. Leyden JJ, McGinley KJ, Cavalieri S, et al. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol. 1983;8:41–5.

    Article  CAS  PubMed  Google Scholar 

  25. Ozolins M, Eady EA, Avery AJ, et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet. 2004;364:2188–95.

    Article  CAS  PubMed  Google Scholar 

  26. Coates T, Eady A, Cove J. Propionibacterial biofilms cannot explain antibiotic resistance but might contribute to some cases of antibiotic recalcitrant acne. Br J Dermatol. 2003;148:366–7.

    Article  CAS  PubMed  Google Scholar 

  27. Mills Jr O, Thornsberry C, Cardin CW, et al. Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle. Acta Derm Venereol. 2002;82:260–5.

    Article  CAS  PubMed  Google Scholar 

  28. Qureshi A, Ross JI, Snelling AM, et al. Survival of antibiotic-resistant Propionibacterium acnes in the environment. 14th European Congress of Clinical Microbiology and Infectious Diseases poster presentation, abstract; 2004

    Google Scholar 

  29. Jakab E, Zbinden R, Gubler J, et al. Severe infections caused by Propionibacterium acnes: an underestimated pathogen in late postoperative infections. Yale J Biol Med. 1996;69:477–82.

    PubMed Central  CAS  PubMed  Google Scholar 

  30. Oprica C, Nord CE. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin Microbiol Infect. 2005;11:204–13.

    Article  CAS  PubMed  Google Scholar 

  31. Cohen M. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 1992;257:1050–5.

    Article  CAS  PubMed  Google Scholar 

  32. Levy RM, Huang EY, Roling D, et al. Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch Dermatol. 2003;139:467–71.

    Article  CAS  PubMed  Google Scholar 

  33. Margolis DJ, Bowe WP, Hoffstad O, et al. Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol. 2005;141:1132–6.

    Article  CAS  PubMed  Google Scholar 

  34. Coates P, Vyakrnam S, Ravenscroft JC, et al. Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne. Br J Dermatol. 2005;153:1126–36.

    Article  CAS  PubMed  Google Scholar 

  35. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol. 2003;49:S1–37.

    Google Scholar 

  36. Coates P, Adams CA, Cunliffe WJ, et al. Does oral isotretinoin prevent Propionibacterium acnes resistance? Dermatology. 1997;195 Suppl 1:4–9. discussion 38–40.

    Article  PubMed  Google Scholar 

  37. Bojar RA, Eady EA, Jones CE, et al. Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc. Br J Dermatol. 1994;130:329–36.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital – Huddinge, SE-141 86, Stockholm, Sweden

    Cristina Oprica

Authors
  1. Cristina Oprica
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cristina Oprica .

Editor information

Editors and Affiliations

  1. Departments of Dermatology, Venereology, Allergology, and Immunology, Dessau Medical Center, Dessau, Germany

    Christos C. Zouboulis

  2. Department of Dermatology, Andreas Syngros Hospital, University of Athens, Athens, Greece

    Andreas D. Katsambas

  3. Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA

    Albert M. Kligman

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Oprica, C. (2014). The Antibiotic Resistance in Acne. In: Zouboulis, C., Katsambas, A., Kligman, A. (eds) Pathogenesis and Treatment of Acne and Rosacea. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69375-8_61

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69375-8_61

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69374-1

  • Online ISBN: 978-3-540-69375-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation